CD44 and glioblastoma: Analysis of the TCGA-GBM dataset showed significant upregulation of CD133 and CD44 stem cell surface markers in GBM tumour tissue compared to non-tumour tissue (Figure 1A,B, left panel), in agreement with previous studies [27].